Accès gratuit
Numéro
Réanimation
Volume 24, Numéro 3, Mai 2015
Infectieux
Page(s) 337 - 343
Section Article Original / Original Article
DOI https://doi.org/10.1007/s13546-015-1068-4
Publié en ligne 10 avril 2015
  • Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965–1976 [CrossRef] [PubMed] [Google Scholar]
  • Jones JL, Kruszon-Moran D, Wilson M, et al (2001) Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 154:357–365 [CrossRef] [PubMed] [Google Scholar]
  • Jeannel D, Niel G, Costagliola D, et al (1988) Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol 17:595–602 [CrossRef] [PubMed] [Google Scholar]
  • Pappas G, Roussos N, Falagas ME (2009) Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39:1385–1394 [CrossRef] [PubMed] [Google Scholar]
  • Schmidt M, Sonneville R, Schnell D, et al (2013) Clinical features and outcomes in patients with disseminated toxoplasmosis admitted to intensive care: a multicenter study. Clin Infect Dis 57:1535–1541 [CrossRef] [PubMed] [Google Scholar]
  • Fernandez-Sabe N, Cervera C, Farinas MC, et al (2012) Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis 54:355–361 [CrossRef] [PubMed] [Google Scholar]
  • Tan IL, Smith BR, von Geldern G, et al (2012) HIV-associated opportunistic infections of the CNS. Lancet Neurol 11:605–617 [CrossRef] [PubMed] [Google Scholar]
  • Sonneville R, Schmidt M, Messika J, et al (2012) Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis. Neurology 79:1762–1766 [CrossRef] [PubMed] [Google Scholar]
  • Antinori A, Larussa D, Cingolani A, et al (2004) Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis 39:1681–1691 [CrossRef] [PubMed] [Google Scholar]
  • Luft BJ, Remington JS (1992) Toxoplasmic encephalitis in AIDS. Clin Infect Dis 15:211–222 [CrossRef] [PubMed] [Google Scholar]
  • Lanoy E, Guiguet M, Bentata M, et al (2011) Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score. Neurology 76:644–651 [CrossRef] [PubMed] [Google Scholar]
  • Sonneville R, Ferrand H, Tubach F, et al (2011) Neurological complications of HIV infection in critically ill patients: clinical features and outcomes. J Infect 62:301–308 [CrossRef] [PubMed] [Google Scholar]
  • Deconinck L, Yazdanpanah Y, Gilson R, et al (2014) Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study. HIV Med 16:219–229 [CrossRef] [PubMed] [Google Scholar]
  • Barbier F, Roux A, Canet E, et al (2014) Temporal trends in critical events complicating HIV infection: 1999–2010 multicentre cohort study in France. Intensive Care Med 40:1906–1915 [CrossRef] [PubMed] [Google Scholar]
  • Abgrall S, Rabaud C, Costagliola D, Clinical Epidemiology Group of the French Hospital Database on HIV (2001) Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis 33:1747–1755 [CrossRef] [PubMed] [Google Scholar]
  • Kotton CN (2007) Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 44:857–866 [CrossRef] [PubMed] [Google Scholar]
  • Hakko E, Ozkan HA, Karaman K, Gulbas Z (2013) Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients. Transpl Infect Dis 15:575–580 [CrossRef] [PubMed] [Google Scholar]
  • Busemann C, Ribback S, Zimmermann K, et al (2012) Toxoplasmosis after allogeneic stem cell transplantation–a single centre experience. Ann Hematol 91:1081–1089 [CrossRef] [PubMed] [Google Scholar]
  • Carteret M, Petit E, Granat O, et al (1995) Spinal cord toxoplasmosis and AIDS. J Radiol 76:453–455 [PubMed] [Google Scholar]
  • Luft BJ, Hafner R, Korzun AH, et al (1993) Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med 329:995–1000 [CrossRef] [PubMed] [Google Scholar]
  • Kumar GG, Mahadevan A, Guruprasad AS, et al (2010) Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature. J Magn Reson Imaging 31:1469–1472 [CrossRef] [PubMed] [Google Scholar]
  • Chang L, Cornford ME, Chiang FL, et al (1995) Radiologicpathologic correlation. Cerebral toxoplasmosis and lymphoma in AIDS. AJNR Am J Neuroradiol 16:1653–1663 [PubMed] [Google Scholar]
  • Schroeder PC, Post MJ, Oschatz E, et al (2006) Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma. Neuroradiology 48:715–720 [CrossRef] [PubMed] [Google Scholar]
  • Dietrich U, Maschke M, Dorfler A, et al (2000) MRI of intracranial toxoplasmosis after bone marrow transplantation. Neuroradiology 42:14–18 [CrossRef] [PubMed] [Google Scholar]
  • Ionita C, Wasay M, Balos L, Bakshi R (2004) MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. Am J Neuroradiol 25:270–273 [Google Scholar]
  • Mueller-Mang C, Mang TG, Kalhs P, Thurnher MM (2006) Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature. Neuroradiology 48:84–89 [CrossRef] [PubMed] [Google Scholar]
  • Westwood TD, Hogan C, Julyan PJ, et al (2013) Utility of FDGPETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIV-infected patients. Eur J Radiol 82:e374–e379 [CrossRef] [PubMed] [Google Scholar]
  • Cingolani A, De Luca A, Ammassari A, et al (1996) PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol 45:472–476 [CrossRef] [PubMed] [Google Scholar]
  • Anselmo LM, Vilar FC, Lima JE, et al (2014) Usefulness and limitations of polymerase chain reaction in the etiologic diagnosis of neurotoxoplasmosis in immunocompromised patients. J Neurol Sci 346:231–234 [CrossRef] [PubMed] [Google Scholar]
  • Shyam Babu C, Satishchandra P, Mahadevan A, et al (2013) Usefulness of stereotactic biopsy and neuroimaging in management of HIV-1 Clade C associated focal brain lesions with special focus on cerebral toxoplasmosis. Clin Neurol Neurosurg 115:995–1002 [CrossRef] [PubMed] [Google Scholar]
  • Brouwer MC, Tunkel AR, van de Beek D (2014) Brain abscess. N Engl J Med 371:1758 [CrossRef] [PubMed] [Google Scholar]
  • Masur H, Brooks JT, Benson CA, et al (2014) Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 58:1308–1311 [CrossRef] [PubMed] [Google Scholar]
  • Katlama C, De Wit S, O’Doherty E, et al (1996) Pyrimethamineclindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 22:268–275 [CrossRef] [PubMed] [Google Scholar]
  • Leport C, Meulemans A, Robine D, et al (1992) Levels of pyrimethamine in serum and penetration into brain tissue in humans. AIDS 6:1040–1041 [CrossRef] [PubMed] [Google Scholar]
  • Torre D, Casari S, Speranza F, et al (1998) Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. Antimicrob Agents Chemother 42:1346–1349 [PubMed] [Google Scholar]
  • Beraud G, Pierre-Francois S, Foltzer A, et al (2009) Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994–2006. Am J Trop Med Hyg 80:583–587 [PubMed] [Google Scholar]
  • Chirgwin K, Hafner R, Leport C, et al (2002) Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039. Clin Infect Dis 34:1243–50 [CrossRef] [PubMed] [Google Scholar]
  • Zolopa A, Andersen J, Powderly W, et al (2009) Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PloS one 4:e5575 [CrossRef] [PubMed] [Google Scholar]
  • Birbeck GL, French JA, Perucca E, et al (2012) Evidence-based guideline: Antiepileptic drug selection for people with HIV/ AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. Neurology 78:139–145 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.